Bicycle Therapeutics
BCYC
$21.36
Share price
-3.70%
Change (1 day)
-11.48%
Change (1 year)
Categories
P/S ratio for Bicycle Therapeutics (BCYC)
P/S ratio as of May 2024 (TTM): 31.3
According to Bicycle Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 31.3042. At the end of 2023 the company had a P/S ratio of 25.3.
P/S ratio history for Bicycle Therapeutics from 2019 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 25.3 | -58.4% |
| 2022 | 60.8 | -60.53% |
| 2021 | 154 | 322.38% |
| 2020 | 36.4 | 196.41% |
| 2019 | 12.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |